Portugal – Medicinal products for the blood, blood-forming organs and the cardiovascular system – 2023/0491 - NATALIZUMAB [20 MG/ML; 15 ML; FRS]

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.